Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
Ahmed M AmerMohamed ZaidBaishali ChaudhuryDalia ElganainyYeonju LeeChristopher T WilkeJordan CloydHuamin WangAnirban MaitraRobert A WolffGauri VaradhacharyMichael J OvermanJeffery E LeeJason B FlemingChing Wei TzengMatthew H KatzEmma B HollidaySunil KrishnanBruce D MinskyJoseph M HermanCullen M TaniguchiPrajnan DasChristopher H CraneOtt LePriya BhosaleEric P TammEugene J KoayPublished in: Cancer (2018)
Changes at the PDAC/parenchyma interface may serve as an early predictor of response to therapy. Cancer 2018;124:1701-9. © 2018 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.